Eton Pharmaceuticals Inc’s filing revealed that its 10% Owner Opaleye Management Inc. acquired Company’s shares for reported $79814.0 on Oct 23 ’24. In the deal valued at $7.98 per share,10,000 shares were bought. As a result of this transaction, Opaleye Management Inc. now holds 2,770,000 shares worth roughly $33.32 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Opaleye Management Inc. bought 33,970 shares, generating $238,782 in total proceeds. Upon buying the shares at $7.03, the 10% Owner now owns 2,760,000 shares.
Before that, Opaleye Management Inc. bought 16,852 shares. Eton Pharmaceuticals Inc shares valued at $114,105 were divested by the 10% Owner at a price of $6.77 per share. As a result of the transaction, Opaleye Management Inc. now holds 2,720,000 shares, worth roughly $32.72 million.
A number of analysts have revised their coverage, including Craig Hallum’s analysts, who began to cover the stock in early May with a ‘”a Buy”‘ rating. H.C. Wainwright maintained its rating on January 04, 2021. It rated ETON as “a Buy”.
Price Performance Review of ETON
On Monday, Eton Pharmaceuticals Inc [NASDAQ:ETON] saw its stock jump 7.12% to $12.03. Over the last five days, the stock has gained 19.94%. Eton Pharmaceuticals Inc shares have risen nearly 174.66% since the year began. Nevertheless, the stocks have risen 220.80% over the past one year. While a 52-week high of $11.44 was reached on 11/25/24, a 52-week low of $3.03 was recorded on 04/17/24. SMA at 50 days reached $8.10, while 200 days put it at $4.89.
Levels Of Support And Resistance For ETON Stock
The 24-hour chart illustrates a support level at 11.49, which if violated will result in even more drops to 10.95. On the upside, there is a resistance level at 12.45. A further resistance level may holdings at 12.87. The Relative Strength Index (RSI) on the 14-day chart is 79.36, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.26, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 7.69%. Stochastics %K at 91.05% indicates the stock is a selling.
How much short interest is there in Eton Pharmaceuticals Inc?
A steep rise in short interest was recorded in Eton Pharmaceuticals Inc stocks on 2024-10-31, growing by 65600.0 shares to a total of 0.19 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 0.13 million shares. There was a rise of 34.18%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 20, 2019 when B. Riley FBR began covering the stock and recommended ‘”a Buy”‘ rating along with a $13.50 price target.
